Narnolia

Narnolia

Toll Free No: 1800-103-7212

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE475.4010.85 (+2.34 %)
PREV CLOSE ( ) 464.55
OPEN PRICE ( ) 470.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 717031
TODAY'S LOW / HIGH ( )467.25 484.90
52 WK LOW / HIGH ( )168 572.7
NSE475.7011.05 (+2.38 %)
PREV CLOSE( ) 464.65
OPEN PRICE ( ) 467.00
BID PRICE (QTY) 475.70 (4406)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8861261
TODAY'S LOW / HIGH( ) 467.00 485.00
52 WK LOW / HIGH ( )161.65 573.05
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
06Aug Glenmark to introduce higher strength
Glenmark Pharmaceuticals is going to introduce a 400 mg version of oral..
23Jul Glenmark declares top-line results fro
Glenmark Pharmaceuticals has declared top-line results from a Phase 3 cl..
23Jul Glenmark shines on declaring top-line
Glenmark Pharmaceuticals is currently trading at Rs. 424.95, up by 11.25..
20Jul Glenmark Pharmaceuticals, ABB India an
Glenmark Pharmaceuticals has launched the world’s first hypertension awa..
18Jul Glenmark Pharmaceuticals launches worl
Glenmark Pharmaceuticals has launched the world’s first hypertension awa..
Financials
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit3491.8813545.48
Gross Profit 3725.53 15346.44
Operating Profit 4527.9919110.18
Net Sales 16077.3467126.31
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
peergroup  8325.80 (1.70%)
M.Cap ( in Cr)19174.84
Lupin (BSE)
peergroup  1018.85 (9.51%)
M.Cap ( in Cr)46168.24
NGL Fine-Chem (BSE)
peergroup  633.90 (7.47%)
M.Cap ( in Cr)391.62
Torrent Pharma (BSE)
peergroup  2839.00 (1.51%)
M.Cap ( in Cr)48038.36
Alkem Laboratories (BSE)
peergroup  2931.25 (0.84%)
M.Cap ( in Cr)35047.49
Shareholding Pattern
PROMOTERS 46.62%
FI/BANKS/INSURANCE 3.16%
NON-INSTITUTION 24.44%
MUTUAL FUNDS/UTI 2.36%
GOVERNMENT 0%
FII 0%
About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 464.55. Its current market capitalisation stands at Rs 13414.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 70091.65 Cr and Total Income of Rs.74847.79 Cr. The company's management includes Saira Ramasastry, D R Mehta, Milind Sarwate, Julio F Ribeiro, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Directory

current IPO
  • --
upcoming IPO
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room